Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 101-110 of 841 for cardiovascular

Edit search filters
  1. Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients

  2. A Study to Collect Electrical Signals From the Heart Using a Special Lead

    Rochester, MN

  3. Rivet PVS Therapy in Group 2C

    Rochester, MN

  4. Lidocaine as an Endotracheal Tube (ETT) Cuff Media

    Rochester, MN

  5. Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

    Rochester, MN

  6. Smart Fabric for Cardio-Performance Enhancement

    Rochester, MN

  7. A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (STELLAR)

    Jacksonville, FL, Rochester, MN

  8. Characteristics of Stem Cells Obtained from the Fat Pat Surrounding the Pericardium

    Jacksonville, FL

  9. Effect of GS-6615 on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

    Rochester, MN

  10. A Study to Evaluate the Safety, Tolerability, Effectiveness, Biological Activity, and Drug/Body Interactions of MYK-461 in Patients with Symptomatic Enlargement of the Heart and Obstruction of Left Ventricle Outflow

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer